From: Factors associated with chronic musculoskeletal pain in patients with chronic kidney disease
All patients n = 456 | No chronic MS pain n = 213 | Chronic MS pain n = 243 | p | |
---|---|---|---|---|
Age (y) | 63.3 ± 14.1 | 62.4 ± 14.5 | 64.6 ± 13.5 | 0.09 |
Male (n, %) | 194 (42.5%) | 64 (30.0%) | 130 (53.5%) | <0.001* |
Body mass index (Kg/m2) | 25.5 ± 3.9 | 25.0 ± 3.4 | 26.3 ± 4.3 | 0.001* |
Waist (cm) | 89.9 ± 10.9 | 87.8 ± 10.2 | 93.2 ± 11.2 | 0.003* |
Smoking (n, %) | 181 (39.7%) | 89 (41.8%) | 92 (37.8%) | 0.754 |
Alcohol use (n, %) | 131 (28.7%) | 65 (30.5%) | 66 (27.2%) | 0.990 |
Betel nut use (n, %) | 26 (5.7%) | 8 (3.8%) | 18 (7.4%) | 0.078 |
NSAID use (n, %) | 40 (7.8%) | 16 (7.5%) | 20 (8.2%) | 0.854 |
Chinese herb use (n, %) | 44 (9.6%) | 22 (10.3%) | 22 (9.1%) | 0.822 |
Co-morbidity | ||||
DM (n, %) | 140 (30.7%) | 75 (35.2%) | 65 (26.7%) | 0.034* |
Hypertension (n, %) | 286 (62.7%) | 124 (58.2%) | 162 (66.7%) | 0.059 |
CAD (n, %) | 35 (7.6%) | 19 (8.9%) | 16 (6.5%) | 0.312 |
PAD (n, %) | 2 (0.4%) | 1 (0.5%) | 1 (0.4%) | 0.935 |
CHF (n, %) | 13 (2.9%) | 7 (3.2%) | 6 (2.4%) | 0.465 |
Stroke (n, %) | 19 (4.2%) | 7 (3.2%) | 12 (4.9%) | 0.429 |
Hyperuricemia (n, %) | 226 (49.6%) | 54 (25.5%) | 172 (71.0%) | <0.001* |
SLE (n, %) | 2 (0.4%) | 1 (0.5%) | 1 (0.4%) | 0.935 |
Urolithiasis (n, %) | 15 (3.3%) | 8 (3.8%) | 7 (2.9%) | 0.502 |
PKD (n, %) | 1 (0.2%) | 1 (0.5%) | 0 (0%) | 0.372 |
RA (n, %) | 3 (0.7%) | 2 (0.9%) | 1 (0.4%) | 0.723 |
Spondylarthropathies (n,%) | 0 (0%) | 0 (0%) | 0 (0%) | 1.000 |
Spine OA (n, %) | 3 (0.7%) | 0 (0%) | 3 (1.2%) | 0.372 |
Back pain (n, %) | 48 (10.5%) | 1 (0.5%) | 48 (19.8%) | <0.001* |
Diuretics use (n, %) | 63 (13.8%) | 27 (12.7%) | 36 (14.8%) | 0.454 |
Allopurinol use (n, %) | 213 (46.7%) | 50 (23.5%) | 163 (67.1%) | <0.001* |
Blood pressure | ||||
Systolic pressure (mm Hg) | 133 ± 19 | 130 ± 18 | 135 ± 19 | 0.006* |
Diastolic pressure (mm Hg) | 73 ± 10 | 73 ± 10 | 74 ± 11 | 0.631 |